Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Effects of Indonesian Marine Sponges Ethanol Extracts on the Lipid Profile of Hyperlipidemic Rats

Wahyuni Wahyuni,Adryan Fristiohady,Muhammad Hajrul Malaka,Fadhliyah Malik,Muhammad Ilyas Yusuf,Mesi Leorita,Baru Sadarun,Ahmad Saleh,Wa Ode Sitti Musnina,Carla W Sabandar,Idin Sahidin.




Abstract
Cited by 12 Articles

This study was aimed to investigate the effects of ethanol extracts of Indonesian marine sponges (Callyspongia sp., Melophlus sarasinorum, and Xestospongia sp.) on the lipid profile of hyperlipidemic rats. The antihyperlipidemic study of these sponges is firstly reported in this study. Experimental hyperlipidemic rats were induced by daily intake of propylthiouracil (1.8 mg/200 g b.wt and quail yolk (10 mL/kg) for a duration of 3 weeks. Hyperlipidemic rat groups were administered orally with three doses (30, 60, and 120 mg/kg) of the ethanol extracts for one-week onwards. Blood sample was then collected via intracardiac puncture and serum was biochemically analyzed. Ethanol extracts of Callyspongia sp., M. sarasinorum, and Xestospongia sp. at doses of 60 and 120 mg/kg exhibited a significant reduction of cholesterols, triglycerides, and LDL. These doses also significantly increased the HDL level. Levels of atherogenic indices (AI, AIP, CRI-I, and CRI-II) were also decreased by both doses with percentages protection ranging from 70.6 to 81.6%. These results showed that ethanol extracts of Callyspongia sp., M. sarasinorum, and Xestospongia sp. exhibited a lipid-lowering activity in hyperlipidemic rats. Hence, these extracts could be used as sources of lead molecules in the development of natural lipid-lowering agents from marine species.

Key words: Antihyperlipidemia, marine sponge, Callyspongia sp., Melophlus sarasinorum, Xestospongia sp.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.